Showing results (131-140 of 310) with videos related to
Sort By:
Pageof 31
Archives of Neurology|December 1, 1991
Etiologic factors for unitemporal vs bitemporal epileptiform dischargesS H Lim, N K So, H Lüders, et al.Australasian Radiology|December 15, 2005
Prioritization of radiotherapy in Australia and New ZealandK S H Lim, S K Vinod, C Bull, et al.TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik|February 13, 2003
Identification and classification of S haplotypes in Raphanus sativus by PCR-RFLP of the S locus glycoprotein (SLG) gene and the S locus receptor kinase (SRK) geneS.-H. Lim, J. Cho, J. Lee, et al.British Journal of Haematology|July 1, 1993
CAMPATH-1 monoclonal antibody therapy in severe refractory autoimmune thrombocytopenic purpuraS H Lim, G Hale, R E Marcus, et al.Annals of Emergency Medicine|February 1, 2017
Comparison of Treatment of Supraventricular Tachycardia by Valsalva Maneuver and Carotid Sinus MassageS H Lim, V Anantharaman, W S Teo, et al.Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|March 1, 1997
T-cell receptor V beta usage by lesional lymphocytes in oral lichen planusD W Thomas, P Stephens, M Stephens, et al.Gut|May 1, 1997
Molecular analysis of T cell receptor beta variability in a patient with orofacial granulomatosisS H Lim, P Stephens, Q X Cao, et al.Bone Marrow Transplantation|July 1, 1997
Cyclosporin A/alpha interferon-induced autologous graft-versus-host disease following peripheral blood stem cell transplant for chronic myeloid leukaemia: a clinico-pathological studyS H Lim, S Coleman, A Bull, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 8, 2015
Circulating tumour cells and circulating nucleic acids as a measure of tumour dissemination in non-metastatic colorectal cancer surgeryS H Lim, K J Spring, P de Souza, et al.Leukemia & Lymphoma|July 27, 2016
High Dose, Short Duration Combination Chemotherapy (MEGA III) for Patients with High Grade Poor Prognosis Non-Hodgkin's Lymphoma-A Phase I/II StudyS H Lim, E M Richards, J Z Wimperis, et al.Pageof 31